NCT01525628: Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients |
|
|
| Completed | 1 | 72 | US, Canada, Europe | midazolam, BI 201335, tenofovir, caffeine, tolbutamide, pegylated interferon, BI 207127, ribavirin | Boehringer Ingelheim | Hepatitis C, Chronic | 12/13 | 10/14 | | |
